About this trial

This study is being done to identify markers and causes of cancer by analyzing patient's DNA (i.e., genetic material), RNA, plasma, tissues, or other samples that could be informative for patients with cancer. Cancer genetic testing is a series of tests that finds specific changes in cancer cells and normal cells in the body. Researchers may request to access these data as they explore how to better prevent, screen, or treat cancer. This study is also being done to create a biobank (library) of samples and information to learn more about treating cancer. Discovery of genetic variants in patients with cancer could result in opportunities for cancer prevention, earlier diagnosis or better therapy for cancer.

Eligibility criteria

Qualifiers

Has Mayo Clinic medical record number

Confirmed cancer diagnosis

Germline and/or somatic tumor/blood testing has been ordered by the clinical provider (or clinical delegate)

Participant aware of cancer diagnosis

Disqualifiers

Individuals who have situations that would limit compliance with the study requirements

Institutionalized (i.e. Federal Medical Prison)

Individuals who have situations that would limit compliance with the study requirements

Institutionalized (i.e. Federal Medical Prison)

Trial design

Treatments tested in this trial

  • Pan-genomic Testing

Treatment groups

500 Participants
are divided into 2 treatment groups

Locations

3
Mayo Clinic in Arizona85259, ScottsdaleArizona, United States
Mayo Clinic in Florida32224, JacksonvilleFlorida, United States
Mayo Clinic in Rochester55905, RochesterMinnesota, United States

Sponsors and collaborators

Mayo Clinic

Lead sponsor